Oncology clinical trials are offered as options for the treatment of cancer. We handle pharmacy, regulatory, and patient related activities locally for pharmaceutical industry studies. We also have access to cooperative group studies as an integral part of the Kaiser Permanente National Cancer Institute (NCI) Community Oncology Research Program (NCORP) consortium. We work with pharmaceutical industry leaders, who are testing novel agents and require further testing and data, to support applications for approval to the Food & Drug Administration (FDA). All study investigators and providers, including our nursing and pharmacy staff, are trained and certified for their role on these clinical trials. Our oncology patients have an opportunity to voluntarily enroll in these studies provided they meet specific enrollment conditions. Kaiser Permanente is proud to be recognized as a national leader in clinical trials enrollment and contributions to the scientific community at large.

Jennifer F. Carney, MD